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Abstract
Noninvasive continuous blood pressure measurements are desirable for 
patients and clinicians. This work proposes and validates a method for 
transmural pressure measurement using photoplethysmography (PPG) in 
an in vitro setup that allows control of pressure and flow conditions. The 
optimum pulsatile volume measure is obtained by comparing parameters 
extracted from the photoplethysmographic signal (AC amplitude, normalized 
pulse volume (NPV) and adjusted pulse volume (APV)). Pulsatile volume 
can then provide pressure measurements using the exponential pressure–
volume (P–V) relationship and validated using the gold standard catheter 
pressure measurement. Pressure, red (R) and infrared (IR) PPG signals were 
recorded continuously in two arterial models with different cross-sectional 
areas (Model 1 and Model 2) utilising a pulsatile pump. Flow rates were 
controlled by varying pumping frequencies at low and high stroke volumes. 
The optimum method for estimation of the pulsatile volume is through APV, 
which had a highly significant correlation (r2  =  0.99, p  <  0.001) for Model 1 
and (r2  =  0.98, p  <  0.001) for Model 2. APV obtained a significantly better 
fit when compared to NPVIR (r2  =  0.73, z  =  25.85, p  <  0.001), NPVR 
(r2  =  0.95, z  =  12.26, p  <  0.001), IRAC (r2  =  0.52, z  =  28.29, p  <  0.0001) 
and RAC (r2  =  0.92, z  =  15.27, p  <  0.0001) in Model 1, and when compared 
to NPVIR (r2  =  0.92, z  =  10.23, p  <  0.0001), NPVR (r2  =  0.96, z  =  5.08, 
p  <  0.001) IRAC (r2  =  0.63, z  =  22.47, p  <  0.0001) and RAC (r2  =  0.92, 
z  =  17.70, p  <  0.0001) in Model 2. These preliminary findings suggest that 
APV could be used as a potential non-invasive continuous method of blood 
pressure measurement at different flow conditions.
H Njoum and P A Kyriacou
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1.  Introduction
Hypertension is the most common condition seen in primary care and is known to lead to 
myocardial infarction, stroke, renal failure, and death if not detected early and treated appro-
priately (James et al 2014). A large body of evidence, from randomised controlled trials, has 
shown the benefits of antihypertensive drug treatments in reducing important health outcomes 
in hypertensive patients (Staessen et al 1997, Beckett et al 2008). Nevertheless, there is also 
evidence that specific drug classes may differ in some effect or in special groups of patients 
(National High Blood Pressure Education Program 2004, Members et al 2013). Noninvasive 
continuous blood pressure (BP) measurement could be proven to be a suitable tool to assess 
the effectiveness of pharmacological and also non-pharmacological treatments.
Noninvasive measurement of blood pressure using the auscultatory method provides ade-
quate data for many applications in medicine. However, some limitations are present that chal-
lenge their applicability in certain clinical situations such as; (1) the method can only provide 
intermittent measurements, a pause of 1–2 min between two BP measurements is necessary to 
avoid errors (Campbell et al 1990), therefore, short-term changes in BP cannot be detected; 
(2) the inflation of the cuff may disturb the patient and as a consequence, alterations of the BP 
can be observed; (3) errors in the technique of the measurement might arise due to the condi-
tions of measurement and arm position. Such problems are more relevant when investigating 
BP fluctuations in critically ill patients, infants or during sleep. An alternative approach is 
continuous, noninvasive measurement of BP which is desirable for monitoring patients dur-
ing and after a major surgical operation or in intensive care units and for home health care. 
Photoplethysmography (PPG) is one of the methods utilised for this purpose using the vascu-
lar unloading method and pulse wave velocity (PWV) approach.
 The vascular unloading technique uses Infrared (IR) transmission PPG to provide ‘raw’ 
continuous pressure readings in commercial devices such as the Finapres, the CNAP, and 
Nexfin (Gibbs et al 1991, Stokes et al 1991, Jeleazcov et al 2010, Weiss et al 2014). In these 
technologies, Finger-IR PPG detects changes in blood volume and is used in conjunction with 
a finger cuff and a servo-controlled pump which adjusts cuff pressure to maintain a constant 
finger blood volume. However, the technique is less accurate during hypotension events or at 
alternating vascular tone (Ilies et al 2012). Other limitations include the potential for patient 
discomfort due to the need for repeated calibration with the brachial artery pressure using an 
oscillometric cuff. The technique is also known to incur reduced precision during periods of 
hemodynamic instability which makes it an unsuitable alternative to direct pressure monitor-
ing (Weiss et al 2014). Moreover, the available commercial devices come with a high price 
tag and are not well suited for personal or home use. Pulse wave velocity (PWV) is the speed 
of a pressure pulse propagating along the arterial wall and can be calculated from pulse transit 
time (PTT). This method has been investigated using a combination of ECG and PPG signals 
(Foo and Lim 2006). While few studies consider the method to be reliable (Ahlstrom et al 
2005, Gesche et al 2012), some question the reliability of this approach as a clinical device 
(Young et al 1995, Payne et al 2006). Investigation in a large number of subjects showed that 
age, BP, gender and cardiovascular risk factors significantly influence PWV (Yamashina et al 
2002, Foo and Lim 2006). The studies suggest that PWV can only be used for measurement 
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of relative BP changes and may encounter errors due to the effect of BP on the measurement 
and the variability of arterial elasticity from one individual to another or due to neurohormonal 
factors.
To investigate the potential of PPG as a technique for noninvasive pressure measurements, 
a more fundamental approach to PPG analysis is proposed. PPG is an optical technique 
mainly applied in pulse oximetry for estimating blood oxygen saturation. The sensor com-
monly uses red (R) and infrared (IR) light sources and a photodetector and is attached to a skin 
surface. The signal provides an oscillatory component (PPGAC) and another steady component 
(PPGDC). Despite the simplicity of the technique, the origin of both components is not well 
understood (de Trafford and Lafferty 1984, Jespersen and Pedersen 1986, Shelley 2007). The 
latter is believed to generate from the low frequency varying functions, such as respiratory and 
thermoregulation and the former is assumed to reflect blood volume change (Kyriacou 2013, 
Abay and Kyriacou 2015). What both components denote hemodynamically have not been 
clarified in a strict manner. A quantification method is constrained by both measures due to the 
gain-dependant nature of the signal. Possibly due to such limitations the raw PPG components 
have been obtained less frequently than other parameters such as blood pressure or heart rate 
(Nijboer et al 1981, Allen 2007).
 Few studies explored the potential of the amplitude of the PPGAC in providing a direct 
measurement of blood pressure. It was reported that the magnitude of the PPGAC is consider-
ably more reliable in providing a measure of arterial blood pressure when compared to PWV. 
However, such findings encountered inaccuracies in standing positions when compared to 
supine positions or weakened correlations during REM sleep phases (Chua and Heneghan 
2006, Chua et al 2010).
The aim of this paper is to present an alternative strategy for the direct measurement of 
noninvasive pressure measurements using the PPG components to overcome the previously 
discussed limitations. This study presents an investigation of the relationship between the PPG 
and pressure signals in an in vitro setup, assuming an exponential pressure–volume (P–V) 
relationship. PPG components at distinct wavelengths were investigated at varied flow rates, 
following changes in the pumping frequency and stroke volume of a pulsatile pump in models 
of a large and small artery. normalised pulse volume (NPV) is advocated on the basis of the 
optical model in the human circulation expressed by Beer–Lambert’s law at each wavelength. 
Similarly, adjusted pulse volume (APV) is defined on the basis of Beer–Lambert’s law utilis-
ing both wavelengths considering the different penetration depths of each wavelength (Ilies 
et al 2012).This is performed in an effort to consider the effect of the oscillatory and the steady 
components of the pulsatile flow, as commonly known from a fluid dynamics point of view 
(Stokes et al 1991).
1.1. Principle
P–V relationship is known to follow an exponential behaviour in the human circulation (Baker 
et al 1997, Burkhoff et al 2005) as noted in (1). Our assumption is that this practice is valid in 
the developed in vitro model which mimics the mechanics of the human circulation.
P b nVexp( )= (1)
Here b and n are parameters of the model.
When we record PPGs from an arterial model, total light intensity can be written as a func-
tion of fluid volume, given that the distance between the light sources and the photodetector is 
constant. The pulsatile volume is a combination of an oscillatory component (Vo) and a steady 
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component (Vs). Assuming that the Beer–Lambert law holds, the following equation expresses 
the relation between the total incident (I0) and total transmitted light (I):
I c V c V Iexp exps s s o o o 0( ) ( )ε ε= − − (2)
Where, c is the concentration of the light-absorbing substance in each component and ε is 
the absorbance coefficient. The subscripts, o and s, denote oscillatory and steady components 
respectively. Given that Vs( ) is constant at the same pressure and wall elasticity, the following 
equation holds for the steady volume component:
I c V Iexp s s s 0( )ε= − (3)
Where, I( ) is constant light intensity obtained from the steady volume layer.
Hence, from (2) and (3), the following can be derived
V c I I. lno o o 1 1 1( ) ( / )ε= − ∆ λ λ− (4)
Where I 1∆ λ  is the amplitude of the oscillatory optical signal, and I 1λ  is the level of the 
steady optical signal, at a particular wavelength 1λ . It is noted that I Iln 1 1( / )λ λ  is in direct pro-
portion to the oscillatory component of the total fluid volume (Vo), via the unknown constant 
term co o( )ε , presuming that both are constant. Hereafter, normalized pulse volume (NPV) is 
given by:
I INVP ln 1 1( / )= − ∆ λ λ (5)
The reliance of the penetration depth on light wavelength is well documented (Stolik et al 
2000), and this concept is used in deriving the adjusted pulse volume (APV). The volume of 
steady flow layer is known to develop in the centre of the tube, where light with higher wave-
length provides a better estimation, and the oscillatory flow occurs in layers closer to the wall, 
where shorter wavelengths provide a more accurate estimate, therefore:
I c V Iexp2 o s s 0( )ε= −λ (6)
Given that 2 1λ λ> , (2) and (6) lead to
V c I I. lno o o 1 1 2( ) ( / )ε= − ∆ λ λ− (7)
Given that co o( )ε  is constant. Hereafter, the adjusted pulse volume (APV) is referred to as
I IAPV ln R IR( / )=− ∆ (8)
Equation (1) can be logarithmically transformed to be rewritten as:
P nV bln lns o( ) ( )= + (9)
Where, Ps is the systolic pressure signal that drives the oscillatory fluid volume. It was previ-
ously noted that NPV and APV are in direct proportion to the oscillatory component of the 
fluid volume (Vo) via the unknown constant term co o( )ε . In this study, both parameters are kept 
constant in a controlled setup to validate the derived relationship. Therefore, (9) can be finally 
rewritten to give the following:
P n bln .NPV lns R( ) ( )= − + (10)
P n bln .NPV lns IR( ) ( )= − + (11)
P n bln .APV lns( ) ( )= − + (12)
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2.  Materials and methods
An in vitro study was carried out to determine the optical response of PPGAC and PPGDC of R 
and IR signals at different flow rates. The in vitro setup, described in the following subsections 
was designed to simulate the flow conditions observed in the healthy and diseased human 
circulation in the range of 45–180 mmHg mean pressure values.
2.1. In vitro prototype
A pulsatile flow loop illustrated in figure 1 was designed and fabricated to contain an elastic 
tube model that produces a range of patterns of mechanical forces at the inner surface of the 
flexible tubing. A pulsatile pump (1423 PBP, Harvard Apparatus, US) was used to generate the 
pulsatile flow. The pump permitted flow regulation by two means: (1) controlling the stroke 
volume, (2) and the pumping rate. A custom-made Plexiglas fluid reservoir (volume: 8 l) con-
tained the fluid within the circulation, was also constructed.
A flexible polyvinyl chloride (PVC) tubing (length: 20 cm, outside diameter (OD): 22 mm, 
and an inner diameter (ID): 16 mm) was connected to the input of the system to enable a fully 
developed flow before entering the model. The model consisted of a PVC tube (Model 1) 
which simulates a large artery and a Tygon tube (Model 2) which simulates a small artery. The 
mechanical properties of each model are listed in table 1.
The model was mounted onto a specially designed support system which incorporated 
rubber clamps to hold the tubes at a constant length without interfering with their move-
ment. An initial axial stretch of 1–2% was used to ensure that the flexible tubes remained in a 
straight position during the pumping phase. One-way check valves with preset opening pres-
sure (50 mmHg) were introduced at both ends of the model which provided the control over 
the resist ance and reflected flow. Valves were also added at the entrance of the design to allow 
control of flow paths and switch to the bypassing tube to eliminate any bubbles in the system. 
The room temperature during all in vitro experiments was maintained at 23  ±  0.5 °C.
2.2. Sensors and instrumentation
2.2.1. Sensors. The reflectance photoplethysmography sensor used was designed and fabri-
cated. Two LEDs, R and IR, at a peak wavelength of 640 nm and 860 nm respectively, were 
aligned in a reflectance mode at a three mm distance from the photodiode (PD) (Vishay, UK). 
A 3D printed (Makerbot, US) encasing was designed and produced to fix the probe at one 
mm contact gap with the pulsating tube without interfering with its motion. The pressure was 
measured at the entrance of the model using a catheter-tip transducer (Harvard Apparatus, US) 
inserted through the lumen of the model. Flow rate was measured at the centre of each tube 
using the MD2 ultrasound Doppler (Huntleigh Healthcare, UK) with an 8 MHz probe. A 3D 
printed holder was designed to fix the probe at a 60° angle with the tube without interfering 
with the wall motion.
2.2.2. Optical processing system. For the acquisition of PPG signals, a custom-made two-
channel dual wavelength PPG instrumentation system was designed. The PPG processing 
system was constructed on printed circuit boards to pre-process and convert the detected 
current into voltages for later acquisition. The processing system used multiplexed current 
sources (set to 25 mA) to drive both red and infrared LEDs consecutively. The microcontroller 
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generated the digital switching clock so that the photodetector captured both wavelengths at a 
frequency of 900 Hz. The mixed PPG signals were fed into the demultiplexer and were then 
split into their respective red and infrared PPG signals. Pressure signals were digitised using 
the 9172-c Data-AcQuisition card (DAQ2) (National Instruments, UK). R and IR PPG signals 
were digitised using the PCIe-6321 (DAQ1) (National Instruments, UK). All signals were 
digitised at a sampling rate of one kHz. Figure 2 shows the in vitro setup with the sensors and 
system configuration.
2.2.3. Measurement protocol. Two litres of hexahydrate cobalt nitrates (Co(NO3)2·6H2O) 
in saline solution (concentration  =  0.6 M) were prepared. The fluid optical spectrum was 
obtained using a sample of the solution in the visible and near infrared range using a spectro-
meter analyser (Lambda 1050, PerkinElmer, US). The reservoir was filled, and the fluid was 
circulated in both models simultaneously for 10 min before data collection in order to allow 
the system to stabilise and eliminate any bubbles. Data collection started for Model 1 for one 
Figure 1. Schematic of the in vitro controlled setup showing arterial model, allocated 
sensors and processing systems.
Table 1. Parameters used during the experiment.
Artery properties Model 1 Model 2
Inside diameter mm 16 6
Outside diameter mm 1.5 1
Elastic modulus (MPa) 28 17
Stroke volume (ml) 30 and 70 30 and 70
Density (g ml) 1.0914 1.0914
Pulsating frequency (Hz) 0.67, 1, 1.8 0.67, 1, 1.8
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minute at each pumping frequency (0.67 Hz, 1 Hz, and 1.8 Hz) at a stroke volume of 30 ml. 
Stroke volume was increased to 70 ml and data recording continued for one minute at the three 
pumping frequency set-points. The protocol was repeated for Model 2. Further parameters are 
listed in table 1.
2.2.4. Data and statistical analysis. The recorded signals were analysed in a customised 
Matlab script (Mathworks, US). PPGAC was extracted using a band-pass filter with a cut-off 
frequency in the range (0.15–30 Hz). PPGDC levels were obtained using a low-pass filter at a 
cut-off frequency of 0.05 Hz. AC magnitudes, DC levels, systolic and diastolic pressures val-
ues were obtained. Cycle-to-cycle data were tabulated for each measurement trial (frequency, 
stroke volume, model). Linear regression fittings were performed following the exponential 
P–V assumed model, providing root mean square error (RMSE) and R-square (r2) values 
which indicate the goodness of curve fitting. Comparison of correlation coefficients was stated 
as a z-value, obtained via the Fisher r-to-z transformation. Comparisons between pulsatile vol-
ume estimation methods to indirectly measure systolic pressure were assessed using Bland–
Altman. The test provides the reproducibility coefficient and % of mean values (RPC (%)) and 
the coefficient of variation (CV); SD of mean values in %.
3.  Results
The collected signals were of high quality. Figure 3 presents a sample of the processed signals 
from Model 1 at a stroke volume of 70 ml for 70 s at each pumping frequencies. Panel (a) 
shows the PPGAC signals at R and IR wavelengths. Panel (b) shows the PPGDC levels at R and 
IR wavelengths. Pressure signals are presented in panel (c). Forward (F1) and reflected (F2) 
flow velocities are presented in panel (d).
An optical spectrum of the circulating fluid was obtained from a sample as can be seen in 
figure 4.
Typical scattergrams and curve fits for pressure versus PPGAC for both models are pre-
sented in figures 5(a) and (b) show natural logarithmic systolic pressure (ln(Ps)) versus R and 
IR PPGAC for Model 1, respectively, where (c) and (d) show ln(Ps)) versus R and IR PPGAC 
Figure 2. Snapshot of the developed setup showing the arterial network model, the 
pump, sensors configuration, processing system and data acquisition system.
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for Model 2. Points include cycle-to-cycle data of 60 s at each pumping frequency and both 
stroke volumes. Fitting equations, values of the goodness of fit (r2 and RMSE) are also listed 
for each function.
 Typical scattergram applying (10)–(12) demonstrating APV, NPVIR, and NPVR for Model 1 
are shown in figure 6, and those for Model 2 are presented in figure 7. Points include cycle-to-cycle 
Figure 3. The collected signals from Model 1 at a stroke volume of 70 ml at varying 
pumping frequencies (0.67, 1 and 1.8Hz). Panel (a) Red (R) and Infrared (IR) PPGAC 
signals, panel (b) R and IR PPGDC levels, panel (c) pressure signals and panel (d) forward 
(F1) and backward (F2) flow velocities
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data of 60 s at each pumping frequency and both stroke volumes. Panel (a) presents ln(Ps)-APV 
function. Panel (b) ln(Ps)-NPVIR function and panel (c) ln(Ps)-NPVR. Fitting equations, values 
of the goodness of fit (r2 and RMSE) are also listed for each function.
To give a representation of the range of the APV method, and to assess the agreement 
between Ps as measured from the pressure transducer directly and as measured from the APV, 
NPVR, NPVIR, RAC and IRAC methods, Bland–Altman plots (Bland and Altman 1986) are 
presented in figure 8 showing comparisons between the direct systolic pressure measurement 
method (Ps) and Ps as obtained from the PPG estimation for all measurement methods (APV, 
NPVIR, NPVR, R PPGAC and IR PPGAC) for Model 1 in panels ((a)–(e)) respectively, and for 
Model 2 in panels ((f)–(j)) respectively.
Figure 4. Absorption spectra for cobalt nitrate solution obtained from the spectrometer 
in the visible and near infrared range.
Figure 5. Linear fitting for natural logarithmic systolic pressure (ln(Ps)) versus PPGAC 
amplitude. (a) ln(Ps) versus infrared (IR) PPGAC obtained from Model 1 (M1). (b) ln(Ps) 
versus IR PPGAC amplitudes obtained from Model 2 (M2). (c) ln(Ps) versus red (R) 
PPGAC amplitudes obtained from M1 and (d) ln(Ps) versus red (R) PPGAC amplitudes 
obtained from M2. Points include cycle-to-cycle data of 60 s at each pumping frequency 
and both stroke volumes.
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4.  Discussion
APV was advocated in the present study as a more valid measure than NPV and raw PPGAC 
for the assessment of fluid pulsatile volume, based on the optical model expressed by Beer–
Lambert’s law. APV superiority to NPV and AC amplitudes are examined from a theoretical 
and an experimental perspective.
Figure 6. Scattergrams for ln(Ps)-V function for Model 1.Panel (a) V is estimated using 
(APV). Panel (b) V is estimated using (NPVIR). Panel (c) V is estimated using (NPVR). 
Points include cycle-to-cycle data of 60 s at each pumping frequency and both stroke 
volumes.
Figure 7. Scattergrams for ln(Ps)-V function for Model 2. Panel (a) V is estimated 
using (APV). Panel (b) V is estimated using (NPVIR). Panel (c) V is estimated (NPVR). 
Points include cycle-to-cycle data of 60 s at each pumping frequency and both stroke 
volumes.
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4.1. Theoretical perspective
What NPV and APV denote hemodynamically can be more clearly identified when compared 
with AC amplitudes. NPV and APV are in direct proportion to the oscillatory component of 
fluid volume Vo insofar as the mean absorption coefficient and the mean concentration of the 
fluid do not change within the model. The pulsatile flow consists of an oscillatory and a steady 
component, therefore, NPV and APV taking into account both PPGAC and PPGDC components 
can be processed as if they are absolute values considering flow velocity profiles, and are in 
direct proportion to Vo. PPGAC amplitude, on the contrary, cannot be processed in such a man-
ner and can only be measured in volts. Moreover, APV brings the advantage of considering 
the depth of penetration of different wavelengths. Previous studies have confirmed that IR 
signals penetrate deeper into tissues, which would suggest satisfactory measurement of the 
steady flow (Stolik et al 2000). However, due to the different absorption characteristics of the 
steady flow region, this might contribute to an error in the PPPGAC signal obtained at higher 
wavelengths. The R PPG signal is known to reach a shallower layer, and on that ground, it can 
be used for a better representation of oscillatory flow. Hence, APV provides a more accurate 
measure of the pulsatile volume by considering oscillatory and steady flow components using 
the relevant wavelengths.
4.2. Experimental perspective
The theoretical expectation that the directly proportional relationship between Vo holds more 
accurately for APV, than NPV and for both methods more than PPGAC amplitudes was indi-
rectly supported by comparing the correlations between APV, NPV and PPGAC amplitudes 
with systolic pressure values using the P–V exponential model. Initially, the optical spectrum 
of the circulating dye is seen in figure 4, which demonstrates lower absorption values in the 
IR region when compared to the red region. The closeness of fit is shown in figures 6 and 7 
confirms the validity of the descriptive model function in the in vitro model. The APV correla-
tion was highly significant (r2  =  0.99, RMSE  =  0.002, n  =  460, p  <  0.0001) for Model 1 and 
(r2  =  0.98, RMSE  =  0.059, n  =  460, p  <  0.0001) for Model 2. NPV obtained insufficient 
correlations (r2  =  0.73, RMSE  =  0.292, n  =  460, p  <  0.0001) for NPVR and significant 
Figure 8. Bland–Altman plots for comparison between the direct systolic pressure 
measurement method (Ps) and Ps as obtained from the PPG estimation for all 
measurement methods (APV, NPVIR,NPVR, R PPGAC and IR PPGAC) for Model 1 in 
panels ((a)–(e)) respectively, and for Model 2 in panels ((f)–(j)) respectively.
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correlation (r2  =  0.95, RMSE  =  0.108, n  =  460, p  <  0.0001) for NPVIR in Model 1. In 
Model 2, NPV obtained significant values (r2  =  0.96, RMSE  =  0.079, n  =  500, p  <  0.0001) 
for NPVR and (r2  =  0.92, RMSE  =  0.109, n  =  500, p  <  0.0001) for NPVIR. In fact, cor-
relation comparisons showed that the APV fit was significantly better than that obtained 
from NPVR (z  =  12.26, p  <  0.0001) and NPVIR (z  =  25.85, p  <  0.0001) in Model 1 and as 
obtained from NPVR (z  =  5.54, p  <  0.0001) and NPVIR (z  =  11.17, p  <  0.0001) in Model 2.
Fittings from the previously assumed hypothesis, where raw AC amplitudes are repre-
sentative of the pulsatile volume are presented in figure 5. Generally, significant correlations 
are observed in both models from R and IR PPGAC signals. However, the Bland–Altman 
agreement test (figure 8) confirms, as seen in panels (d) and (e) for Model 1 and panels (i) 
and (j) for Model 2 that this agreement is not significant (p  >  0.05). Additionally, NPVR 
showed a significant agreement in both models, yet NPVIR was in significant agreement only 
in Model 2. This highlights that the APV method might be more beneficial in larger arteries, 
wherein smaller arteries, both signals penetrate deep enough to provide a good estimation of 
the oscillatory and steady components, hence, the NPV and APV methods provide significant 
agreements as observed in Model 2. Nevertheless, APV provided the strongest agreement in 
both models compared to the rest of the methods as seen from r2 correlation values in figures 6 
and 7 and as confirmed by the Bland–Altman method comparison test and the obtained RPC 
and CV values seen in figure 8.
It is evident that AC amplitudes are affected by flow dynamics, whether it is pumping fre-
quencies, stroke volumes, or a change in cross-sectional areas. The results confirm that AC 
amplitudes are sensitive to a change in the total section area/volume of the model and can indi-
cate vasoconstriction or reduced blood volume, as R and IR PPGAC values were significantly 
less in Model 2 when compared to Model 1. Moreover, the general trend underlines that raw 
AC amplitudes respond to an increase in pressure values by increasing due to an increase in 
frequencies as seen in figure 3, however, there are cases where AC failed to reflect an increase 
in pressure, specifically at increased stroke volumes. By observing the DC levels seen in 
 figure 3, we infer that PPGAC behaviour is attributed to flow profiles, where steady and oscilla-
tory components interact to maximise the velocity of the steady layer in the centre of the tube. 
At the case where flow velocities increased significantly at high stroke volume in Model 1, the 
flow might act in a way to compensate its oscillatory component to maintain the efficiency of 
the steady layer. This further highlights the suitability of the APV method when compared to 
PPGAC amplitudes and NPV methods due to its consideration of the depth of light penetration, 
and dismissing potential errors in the case of steady layer expansion.
4.3. Limitations of the study
This in vitro controlled study is aimed to address some fundamental questions, and hence, it 
encounters some limitations that can be addressed. The basic assumption for the derivation 
equations considers the fluid as a non-scattering homogeneous medium. However, this pre-
sumption is not valid for blood suspension because the light interaction through the suspen-
sion is caused by absorption, as well as scattering events (Friebel et al 2006). Nonetheless, the 
evidence is accumulating that Beer–Lamber’s law can be extended to a light scattering system 
(Kocsis et al 2006). It is also possible that light scattering of blood suspensions is constant 
under normal circulatory states.
The factors which can violate the directly proportional relationship between Vo were not 
investigated experimentally in this study (c and ε). Yet, during an in vivo setup, ε is con-
stant within and between subjects due to the fixed absorption coefficients of oxy and 
99
deoxyhemoglobin at the specific wavelength. In respect to c, haematocrit changes are expected 
to be only a few percent due to changes in neurohormonal factors. Moreover, such changes 
might be indirectly represented in the obtained optical signal due to their effect on the optical 
density of the medium and the resultant haemodynamic changes associated with such factors.
Another limitation of this study is the use of the arbitrary values generated from the curve 
fitting. In fact, previous studies have considered the constant (n) in (1) as a measure of stiff-
ness index. It is evident that this constant indicates the increase in stiffness in Model 1 (0.96) 
when compared to Model 2 (0.86) (Tanaka et al 2011). This limitation can be overcome by 
introducing a calibration assessment where n and b are estimated for each subject prior to the 
measurement.
Finally, previous investigations of the relationship between pressure and PPGAC in human 
studies reported the inverse of the relationship observed in this study as seen in figure 3 (i.e. 
light attenuation and a drop in AC amplitudes were observed with increasing pressures) (Weiss 
et al 2014). This can be attributed to the augmentation in vascular resistance with increasing 
pressure by the effect of vasoconstriction due to endothelial activation and, therefore, the 
expected drop in total volume. Hence, it is expected that the proposed approach would still be 
valid in a human study.
5.  Conclusion
Despite the limitations, our study validated the proposed APV method in a large and small 
artery models within a wide range of mean pressure values 45–180 mmHg (0.006–0.024 MPa), 
controlled by means of flow rates and stroke volumes. Correlation and Bland–Altman com-
parisons between PPGAC, NPV and APV showed that the APV fit was significantly better than 
that obtained from NPVR, NPVIR, and raw R and IR PPGAC amplitudes in both models. In con-
clusion, APV could be a potential method used in noninvasive measurement devices of blood 
pressure. Further, in vivo investigations are required to validate this method for clinical use.
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